Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesVolpara Health Technologies Ltd

Volpara Health Technologies Ltd

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
None AUD 0.00(0%)
Last update at 2024-06-24T06:45:02.418326Z
Market Cap
291.26M

Momentum Score

…

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand. As of May 13, 2024, Volpara Health Technologies Limited operates as a subsidiary of Lunit Inc..

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.62
Low
1.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
37.96M
Revenue Per Share
0.15
Gross Profit TTM
23.82M
Debt / Equity
0.04
ROE
-17.33%
Net Debt
-9.95M
ROCE
-20.84%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -10.65M -15.01M -17.40M -21.71M -11.26M
Net income -9.17M -15.28M -16.05M -19.83M -11.24M
Selling general administrative 12.45M 11.39M 11.51M 11.59M 2.92M
Selling and marketing expenses 14.29M 13.12M 11.28M 12.92M 8.08M
Gross profit 30.30M 22.14M 16.57M 10.59M 3.95M
Reconciled depreciation 5.13M 4.33M 2.84M 2.18M 0.30M
Ebit -10.30M -14.88M -17.26M -21.64M -11.20M
Ebitda -5.17M -10.55M -14.43M -19.46M -10.90M
Depreciation and amortization 5.13M 4.33M 2.84M 2.18M 0.30M
Operating income -10.30M -14.88M -17.26M -21.64M -12.75M
Other operating expenses 50.89M 46.63M 40.19M 39.05M 17.54M
Interest expense 0.35M 0.13M 0.13M 0.07M 0.06M
Tax provision -1.48M 0.27M -1.34M -1.94M -0.01M
Interest income 0.17M 0.16M 0.57M 0.70M 0.41M
Net interest income -0.18M 0.03M 0.44M 0.68M 0.39M
Income tax expense -1.48M 0.27M -1.34M -1.89M -0.01M
Total revenue 32.77M 24.27M 18.13M 12.32M 4.79M
Total operating expenses 48.42M 44.50M 38.63M 37.32M 16.70M
Cost of revenue 2.47M 2.13M 1.55M 1.73M 0.84M
Total other income expense net -0.35M -0.13M -0.13M -0.07M 1.49M
Net income from continuing ops -9.17M -15.28M -16.05M -19.86M -11.24M
Net income applicable to common shares -9.80M -16.44M -17.49M -20.37M -11.74M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 74.15M 75.27M 86.86M 71.10M 18.17M
Intangible assets 23.44M 23.85M 24.94M 17.56M 0.34M
Other current assets 1.00M 0.66M 0.41M 0.38M 0.39M
Total liab 26.18M 21.47M 20.03M 20.19M 4.59M
Total stockholder equity 47.97M 53.81M 66.83M 50.91M 13.58M
Deferred long term liab - 2.33M 1.75M 1.59M 0.93M
Other current liab 4.31M 3.79M 2.68M 3.59M 1.73M
Common stock 171.55M 168.69M 165.87M 136.57M 80.57M
Capital stock 171.55M 168.69M 165.87M 136.57M 80.57M
Retained earnings -127.05M -117.39M -101.03M -90.21M -69.15M
Other liab - 0.29M 1.14M 1.64M 0.02M
Good will 20.21M 17.96M 17.68M 8.02M -
Other assets 3.84M 2.42M 1.83M 1.59M 0.94M
Cash 11.90M 16.86M 29.59M 30.59M 13.77M
Cash and equivalents - - 2.00M 0.00M 1.75M
Total current liabilities 24.74M 19.43M 16.32M 15.51M 4.45M
Current deferred revenue 18.91M 13.91M 10.50M 10.46M 2.07M
Net debt -9.95M -14.56M -24.65M -26.92M -13.53M
Short term debt 0.51M 0.53M 2.27M 0.59M 0.12M
Short long term debt - - 1.83M - 0.12M
Short long term debt total 1.95M 2.30M 4.93M 3.67M 0.24M
Other stockholder equity 0.00M 2.69M 2.18M -0.04M 0.00M
Property plant equipment 2.28M 2.79M 3.41M 4.55M 0.55M
Total current assets 24.39M 28.29M 39.43M 39.53M 16.40M
Long term investments 0.38M 0.33M - - -
Net tangible assets - 12.90M 26.37M 25.99M 13.83M
Short term investments 5.40M 0.28M 24.36M 27.70M 10.27M
Net receivables 10.23M 8.80M 7.91M 7.35M 2.20M
Long term debt - 0.00M 0.45M - 0.13M
Inventory 1.27M 1.69M 0.05M 0.05M 0.03M
Accounts payable 1.01M 1.19M 0.87M 0.86M 0.52M
Accumulated other comprehensive income 3.47M 2.50M 2.00M 4.59M 2.17M
Common stock total equity - - 165.87M 136.57M 80.57M
Non currrent assets other 2.88M 2.17M 1.61M 1.55M 0.90M
Non current assets total 49.75M 46.98M 47.43M 31.56M 1.77M
Capital lease obligations 1.95M 2.30M 2.66M 3.67M 0.24M
Long term debt total 1.53M 1.91M 2.90M 3.16M 0.13M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments 2.75M 15.50M 2.35M -16.60M -8.77M
Change to liabilities 0.00M 3.79M 0.85M 6.61M 2.01M
Total cashflows from investing activities 2.94M 13.20M -23.11M -39.31M -9.46M
Net borrowings - -0.54M 2.22M -0.29M -0.09M
Total cash from financing activities 0.50M -0.02M 38.44M 53.85M 19.82M
Change to operating activities - -0.84M -0.51M -0.60M -0.63M
Net income -9.17M -15.28M -16.05M -19.83M -11.24M
Change in cash 0.03M 1.68M 3.86M -0.43M 0.74M
Begin period cash flow 9.06M 7.32M 3.37M 4.01M 3.20M
End period cash flow 9.09M 8.99M 7.23M 3.58M 3.94M
Total cash from operating activities -9.17M 4.33M -12.87M -15.56M -10.64M
Issuance of capital stock 1.05M 0.47M 37.86M 57.18M 20.84M
Depreciation 2.86M 4.33M 2.84M 2.18M 0.30M
Other cashflows from investing activities 5.51M 15.37M -22.28M -38.99M -8.77M
Change to inventory - - 0.00M -0.01M -0.02M
Change to account receivables - -0.48M -1.34M -2.96M -1.09M
Sale purchase of stock 1.12M 0.51M -1.47M -3.04M -0.94M
Other cashflows from financing activities -0.55M -0.50M 2.04M -0.28M -0.08M
Change to netincome - -2.04M 1.38M -1.53M 0.51M
Capital expenditures 2.40M 2.02M 0.76M 0.98M 0.66M
Change in working capital 0.47M 0.37M 1.57M 1.40M 1.04M
Other non cash items 9.17M 10.95M 13.22M 17.68M 10.95M
Free cash flow -11.58M 2.31M -13.63M -16.54M -10.86M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PME
Pro Medicus Ltd		 -3.10
1.49%		 205.13 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd		 -0.13
5.39%		 2.28 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd		 -0.09
2.66%		 3.29 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd		 -
-%		 3.50 - - 20505.14 7.00 16927.51 0.33

Profile*

Volpara Health Technologies Ltd

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand. As of May 13, 2024, Volpara Health Technologies Limited operates as a subsidiary of Lunit Inc..

40 Mercer Street, Wellington, New Zealand, 6011

64 4 499 6029

https://www.volparahealth.com

156

Name Title Year Born
Dr. Ralph P. Highnam B.Sc., M.Sc., Ph.D. Founder, MD, Chief Scientist & Chief Science and Innotion Officer NA
Mr. Craig Hadfield CFO & Company Sec. NA
Ms. Teri Thomas CEO, MD & Director NA
Prof. Nico Karssemeijer Co-Founder & Member of Scientific Board NA
Mr. Tana Isaac Exec. VP of Product & Technology NA
Mr. Gareth Beaumont Chief Information Officer & Chief Information Security Officer NA
Mr. Fred Struve B.Sc., J.D. Joint Company Sec. & Gen. Counsel NA
Ms. Jill Spear Exec. VP of Sales & Marketing NA
Ms. Kathryn Greene Chief People Officer NA
Mr. Julian Marshall Chief Knowledge Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…